Familial Amyloid Polyneuropathies
2 clinical trials · Condition
◉ Watch Familial Amyloid Polyneuropathies
| Record | Firm | Date |
|---|---|---|
| APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis (NCT01960348) | Alnylam Pharmaceuticals | 2013-11-01 |
| Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR) (NCT02939820) | Alnylam Pharmaceuticals |
Track Familial Amyloid Polyneuropathies automatically
Every clearance here is in the API, with alerts when new ones post.